STOCKWATCH
·
Healthcare Service Provider
New Launch4 Jul 2025, 04:23 pm

Suraksha Diagnostic Launches Eastern India's Largest Genomics Lab with 22 Crore Investment

AI Summary

Suraksha Diagnostic Limited, a leading diagnostics chain in Eastern India, has launched a state-of-the-art genomics lab in Kolkata, West Bengal. The lab, equipped with advanced technologies like Cytogenetics, Microarray Technology, Sanger Sequencing, and Next-Generation Sequencers, offers predictive, preventive, and personalized care. The lab enables the detection of chromosomal abnormalities and hereditary cancer testing panels, aiding in early detection and better treatment planning. Suraksha Diagnostic has invested 22 crores in establishing the lab and plans to invest an additional 46 crores over the next 24 months. This initiative is a significant leap forward for West Bengal and Eastern & North-Eastern India in precision diagnostics.

Key Highlights

  • Suraksha Diagnostic launches Eastern India's largest genomics lab in Kolkata, West Bengal.
  • The lab is equipped with advanced technologies like Cytogenetics, Microarray Technology, Sanger Sequencing, and Next-Generation Sequencers.
  • The lab enables the detection of chromosomal abnormalities and hereditary cancer testing panels, aiding in early detection and better treatment planning.
  • Suraksha Diagnostic has invested 22 crores in establishing the lab and plans to invest an additional 46 crores over the next 24 months.
  • This initiative is a significant leap forward for West Bengal and Eastern & North-Eastern India in precision diagnostics.
SURAKSHA
Healthcare Service Provider
Suraksha Diagnostic Ltd

Price Impact